EZH2 and diffuse large B-cell lymphoma: UNC1999 showed high efficacy in vitro against wild-type and mutant EZH2 and EZH1, effectively reducing the level of H3K27me3 in cells and selectively killing diffuse large B-cell lymphoma cell lines containing EZH2Y641N mutation with low cytotoxicity [105].